Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients

European Journal of Cancer

Volumn 51, Issue 3, 2015, Pages 382-390

  Roth, Patrick ^a   Keller, Andreas ^b   Hoheisel, Jörg D ^c   Codo, Paula ^a   Bauer, Andrea S ^c   Backes, Christina ^d   Leidinger, Petra ^d   Meese, Eckart ^d   Thiel, Eckhard ^e   Korfel, Agnieszka ^e   Weller, Michael ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b SAARLAND UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biomarker; microRNA; Next generation; Primary CNS lymphoma; Prognostic factor; sequencing

Indexed keywords

MICRORNA; MICRORNA 106A 5P; MICRORNA 151A 5P; MICRORNA 151B; MICRORNA 17 5P; MICRORNA 181C 3P; MICRORNA 183 3P; MICRORNA 194 5P; MICRORNA 219 5P; MICRORNA 30D 5P; MICRORNA 503 5P; MICRORNA 6130; MICRORNA 96 5P; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FINGER DERMATOGLYPHICS; HUMAN; KARNOFSKY PERFORMANCE STATUS; LONG TERM SURVIVAL; NEXT GENERATION SEQUENCING; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SHORT TERM SURVIVAL; SURVIVAL TIME; BLOOD; CENTRAL NERVOUS SYSTEM TUMOR; COHORT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LYMPHOMA; MALE; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PROGNOSIS; SURVIVAL; SURVIVOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA; MALE; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; SURVIVORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84922669735     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.10.028     Document Type: Article

References (24)

1. P. Roth, R. Stupp, G. Eisele, and M. Weller Treatment of primary CNS lymphoma Curr Treat Options Neurol 16 1 2014 277
2. A. Korfel, and U. Schlegel Diagnosis and treatment of primary CNS lymphoma Nat Rev Neurol 9 6 2013 317 327
3. E.M. Bessell, F. Graus, A. Lopez-Guillermo, S.A. Lewis, S. Villa, and E. Verger Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors Int J Radiat Oncol Biol Phys 59 2 2004 501 508
4. A.J. Ferreri, J.Y. Blay, M. Reni, F. Pasini, M. Spina, and A. Ambrosetti Prognostic scoring system for primary CNS lymphomas: the international extranodal lymphoma study group experience J Clin Oncol 21 2 2003 266 272
5. L.E. Abrey, L. Ben-Porat, K.S. Panageas, J. Yahalom, B. Berkey, and W. Curran Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model J Clin Oncol 24 36 2006 5711 5715
6. O. Levy, L.M. Deangelis, D.A. Filippa, K.S. Panageas, and L.E. Abrey Bcl-6 predicts improved prognosis in primary central nervous system lymphoma Cancer 112 1 2008 151 156
7. S. Kreher, F. Strehlow, P. Martus, P. Roth, B. Hertenstein, and A. Röth Prognostic impact of intraocular involvement in primary CNS lymphoma: experience from the G-PCNSL-SG1 trial Ann Hematol 2014
8. R.A. Shivdasani MicroRNAs: regulators of gene expression and cell differentiation Blood 108 12 2006 3646 3653
9. C. Baer, R. Claus, and C. Plass Genome-wide epigenetic regulation of miRNAs in cancer Cancer Res 73 2 2013 473 477
10. L. Fischer, M. Hummel, A. Korfel, D. Lenze, K. Joehrens, and E. Thiel Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas Neuro Oncol 13 10 2011 1090 1098
11. M.V. Iorio, and C.M. Croce MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review EMBO Mol Med 4 3 2012 143 159
12. A. Baraniskin, J. Kuhnhenn, U. Schlegel, A. Chan, M. Deckert, and R. Gold Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system Blood 117 11 2011 3140 3146
13. E. Thiel, A. Korfel, P. Martus, L. Kanz, F. Griesinger, and M. Rauch High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial Lancet Oncol 11 11 2010 1036 1047
14. A. Keller, P. Leidinger, A. Bauer, A. Elsharawy, J. Haas, and C. Backes Toward the blood-borne miRNome of human diseases Nat Methods 8 10 2011 841 843
15. S.F. Hausler, A. Keller, P.A. Chandran, K. Ziegler, K. Zipp, and S. Heuer Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening Br J Cancer 103 5 2010 693 700
16. P. Roth, J. Wischhusen, C. Happold, P.A. Chandran, S. Hofer, and G. Eisele A specific miRNA signature in the peripheral blood of glioblastoma patients J Neurochem 118 3 2011 449 457
17. Y. Benjamini, D. Drai, G. Elmer, N. Kafkafi, and I. Golani Controlling the false discovery rate in behavior genetics research Behav Brain Res 125 1-2 2001 279 284
18. A. Keller, N. Ludwig, N. Comtesse, A. Hildebrandt, E. Meese, and H.P. Lenhof A minimally invasive multiple marker approach allows highly efficient detection of meningioma tumors BMC Bioinformatics 7 2006 539
19. M. Lu, B. Shi, J. Wang, Q. Cao, and Q. Cui TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs BMC Bioinformatics 11 2010 419
20. P. Leidinger, C. Backes, S. Deutscher, K. Schmitt, S.C. Mueller, and K. Frese A blood based 12-miRNA signature of Alzheimer disease patients Genome Biol 14 7 2013 R78
21. P. Roth, M. Junker, I. Tritschler, M. Mittelbronn, Y. Dombrowski, and S.N. Breit GDF-15 contributes to proliferation and immune escape of malignant gliomas Clin Cancer Res 16 15 2010 3851 3859
22. No Authors A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project N Engl J Med 329 14 1993 987 994
23. A. Keller, P. Leidinger, J. Lange, A. Borries, H. Schroers, and M. Scheffler Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls PLoS One 4 10 2009 e7440
24. A. Baraniskin, J. Kuhnhenn, U. Schlegel, W. Schmiegel, S. Hahn, and R. Schroers MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma J Neurooncol 109 2 2012 239 244